<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Problems</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Progress Notes</a></li><li><a href="#id10">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">codeine</td><td>Codeine</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy2">tramadol</td><td>Tramadol</td><td ID="reaction2">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy3"/><td>Penicillin</td><td ID="reaction3">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>NF f/u</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Carvedilol 12.5 MG</td><td ID="instruction1">1 tablet with food Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Cholecalciferol 25 MCG (1000 UT)</td><td ID="instruction2">1 capsule Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Albuterol Sulfate 108 (90 Base) MCG/ACT</td><td ID="instruction3">1 puff as needed Inhalation every 4 hrs</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Atorvastatin Calcium 40 MG</td><td ID="instruction4">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Bisacodyl 10 MG</td><td ID="instruction5">1 suppository as needed Rectal Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Losartan Potassium 50 MG</td><td ID="instruction6">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Milk of Magnesia 1200 MG/15ML</td><td ID="instruction7">5 mL as needed Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Clopidogrel Bisulfate 75 MG</td><td ID="instruction8">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">hydrALAZINE HCl 25 MG</td><td ID="instruction9">1 tablet with food Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">traZODone HCl 150 MG</td><td ID="instruction10">1 tablet at bedtime Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Tylenol 325 MG</td><td ID="instruction11">1 capsule as needed Orally every 6 hrs</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">Trelegy Ellipta 100-62.5-25 MCG/ACT</td><td ID="instruction12">1 puff Inhalation Once a day</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>127013003</td><td ID="Problem1">Chronic kidney disease due to diabetes mellitus (E11.22)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>44054006</td><td ID="Problem2">Type 2 diabetes mellitus with other specified complication (E11.69)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>713706002</td><td ID="Problem3">Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin (E11.42)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>129161000119100</td><td ID="Problem4">Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease (I12.0)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>105502003</td><td ID="Problem5">Dependence on renal dialysis (Z99.2)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>412768003</td><td ID="Problem6">BMI 23.0-23.9, adult (Z68.23)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Blood pressure systolic</th><td>132 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure diastolic</th><td>70 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Heart Rate</th><td>76 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Respiratory Rate</th><td>18 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Weight</th><td>170 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Height</th><td>72 in</td><td>[REDACTED]</td></tr><tr><th ID="vital7">BMI</th><td>23.05 kg/m2</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Pinellas Point Nursing &amp; Rehab Center</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease I12.0 ; Dependence on renal dialysis Z99.2 ; End stage renal disease N18.6 ; Chronic kidney disease due to diabetes mellitus E11.22 ; Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin E11.42 ; Type 2 diabetes mellitus with other specified complication E11.69 ; Hyperlipidemia, unspecified E78.5 ; Ischemic cardiomyopathy I25.5 ; Chronic obstructive pulmonary disease, unspecified J44.9 ; Pleural effusion, not elsewhere classified J90 ; Primary insomnia F51.01 ; Other chronic pain G89.29 and BMI 23.0-23.9, adult Z68.23</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease (ICD-10 - I12.0)</td><td/><td><p>Blood pressure management with medications.</p><p>- Continue current medications for blood pressure management. Medication as directed, take your blood pressure daily. Monitor renal indices, following a kidney-friendly diet, limiting sodium intake, avoid nephrotoxins</p></td><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Dependence on renal dialysis (ICD-10 - Z99.2)</td><td/><td><p>Patient is on hemodialysis. Monitoring for worsening symptoms.</p><p>- Continue hemodialysis.</p></td><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>End stage renal disease (ICD-10 - N18.6)</td><td/><td><p>Patient is on hemodialysis. Monitoring for worsening symptoms.</p><p>- Continue hemodialysis.</p></td><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Chronic kidney disease due to diabetes mellitus (ICD-10 - E11.22)</td><td/><td><p>Management with Insulin and [REDACTED].</p><p>- Continue Insulin and Losartan 100 milligram tab. </p><p>monitor renal indices, avoid nephrotoxins, renal to follow PRN</p></td><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin (ICD-10 - E11.42)</td><td/><td>Advised healthy diet, control blood glucose, engage in regular physical activity/exercise, get adequate sleep, manage other risk factors, weight loss</td><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication (ICD-10 - E11.69)</td><td/><td>Advised strict adherence to diabetic diet, with focus on lowering cholesterol and triglycerides by dietary choices, take medications as prescribed</td><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Hyperlipidemia, unspecified (ICD-10 - E78.5)</td><td/><td><p>Management with Atorvastatin.</p><p>- Continue Atorvastatin 40MG tab once daily.</p></td><td>-</td><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Ischemic cardiomyopathy (ICD-10 - I25.5)</td><td/><td><p>Continue current medication regimine </p><p>Monitor for symptoms</p></td><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified (ICD-10 - J44.9)</td><td/><td><p>Well controlled on Trilogy inhaler. Utilize Albuterol as needed.</p><p>- Continue Trilogy inhaler.</p><p>- Utilize Albuterol as needed.</p></td><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Pleural effusion, not elsewhere classified (ICD-10 - J90)</td><td/><td><p>Recent hospitalization for acute on chronic shortness of breath. Secondary to bibasilar effusion.</p><p>- Monitor for dyspnea and increased cough.</p></td><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Primary insomnia (ICD-10 - F51.01)</td><td/><td><p>- Continue Trazodone 150 milligrams.</p><p>- Encourage sleep hygiene.</p></td><td/><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Other chronic pain (ICD-10 - G89.29)</td><td/><td><p>Pain currently controlled on current regimen. Deferred to pain management.</p><p>- Continue current pain management regimen.</p><p>- Deferred to pain management.</p></td><td/><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>BMI 23.0-23.9, adult (ICD-10 - Z68.23)</td><td/><td>Counseled the patient regarding maintaining a healthy body mass index and explained to them the importance of diet restrictions and exercising.</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease</td><td><p>Blood pressure management with medications.</p><p>- Continue current medications for blood pressure management. Medication as directed, take your blood pressure daily. Monitor renal indices, following a kidney-friendly diet, limiting sodium intake, avoid nephrotoxins</p></td></tr><tr><td ID="instructionpot2">Dependence on renal dialysis</td><td><p>Patient is on hemodialysis. Monitoring for worsening symptoms.</p><p>- Continue hemodialysis.</p></td></tr><tr><td ID="instructionpot3">End stage renal disease</td><td><p>Patient is on hemodialysis. Monitoring for worsening symptoms.</p><p>- Continue hemodialysis.</p></td></tr><tr><td ID="instructionpot4">Chronic kidney disease due to diabetes mellitus</td><td><p>Management with Insulin and Losartan.</p><p>- Continue Insulin and Losartan 100 milligram tab. </p><p>monitor renal indices, avoid nephrotoxins, renal to follow PRN</p></td></tr><tr><td ID="instructionpot5">Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin</td><td>Advised healthy diet, control blood glucose, engage in regular physical activity/exercise, get adequate sleep, manage other risk factors, weight loss</td></tr><tr><td ID="instructionpot6">Type 2 diabetes mellitus with other specified complication</td><td>Advised strict adherence to diabetic diet, with focus on lowering cholesterol and triglycerides by dietary choices, take medications as prescribed</td></tr><tr><td ID="instructionpot7">Hyperlipidemia, unspecified</td><td><p>Management with Atorvastatin.</p><p>- Continue Atorvastatin 40MG tab once daily.</p></td></tr><tr><td ID="instructionpot8">Ischemic cardiomyopathy</td><td><p>Continue current medication regimine </p><p>Monitor for symptoms</p></td></tr><tr><td ID="instructionpot9">Chronic obstructive pulmonary disease, unspecified</td><td><p>Well controlled on Trilogy inhaler. Utilize Albuterol as needed.</p><p>- Continue Trilogy inhaler.</p><p>- Utilize Albuterol as needed.</p></td></tr><tr><td ID="instructionpot10">Pleural effusion, not elsewhere classified</td><td><p>Recent hospitalization for acute on chronic shortness of breath. Secondary to bibasilar effusion.</p><p>- Monitor for dyspnea and increased cough.</p></td></tr><tr><td ID="instructionpot11">Primary insomnia</td><td><p>- Continue Trazodone 150 milligrams.</p><p>- Encourage sleep hygiene.</p></td></tr><tr><td ID="instructionpot12">Other chronic pain</td><td><p>Pain currently controlled on current regimen. Deferred to pain management.</p><p>- Continue current pain management regimen.</p><p>- Deferred to pain management.</p></td></tr><tr><td ID="instructionpot13">BMI 23.0-23.9, adult</td><td>Counseled the patient regarding maintaining a healthy body mass index and explained to them the importance of diet restrictions and exercising.</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 Weeks,prn, Reason: f/u</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 939463 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">NH - F/Up</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>939463</td><td align="right"><span class="bold">Provider: </span>[REDACTED], APRN</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>72 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. NF f/u. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">HPI</span>: <br/>       [REDACTED] M being seen for management of his chronic conditions at SNF. PMH stated below. Pt is in NAD at bedside. Per nursing no new issues verbalized.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="content_span">A complete ROS is done and is otherwise negative except for those listed above.</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> SOB, Ischemic colitis, Bed bound, Insomnia, managed with trazodone.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> baypines-chronic sob,esrd [REDACTED], Acute on chronic shortness of breath secondary to bibasilar effusion, va bay pines, [REDACTED] 03/2025. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Son(s): alive. 1 son(s) . . <br/><span class="content_span">spouse</span>.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   not reported.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking Tylenol 325 MG Capsule 1 capsule as needed Orally every 6 hrs , Taking Trelegy Ellipta 100-62.5-25 MCG/ACT Aerosol Powder Breath Activated 1 puff Inhalation Once a day , Taking traZODone HCl 150 MG Tablet 1 tablet at bedtime Orally Once a day , Taking Milk of Magnesia 1200 MG/15ML Suspension 5 mL as needed Orally Once a day , Taking Losartan Potassium 50 MG Tablet 1 tablet Orally Once a day , Taking hydrALAZINE HCl 25 MG Tablet 1 tablet with food Orally Twice a day , Taking Clopidogrel Bisulfate 75 MG Tablet 1 tablet Orally Once a day , Taking Cholecalciferol 25 MCG (1000 UT) Capsule 1 capsule Orally Once a day , Taking Carvedilol 12.5 MG Tablet 1 tablet with food Orally Twice a day , Taking Bisacodyl 10 MG Suppository 1 suppository as needed Rectal Once a day , Taking Atorvastatin Calcium 40 MG Tablet 1 tablet Orally Once a day , Taking Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Powder Breath Activated 1 puff as needed Inhalation every 4 hrs , Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Codeine, Penicillin, Tramadol. </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> BP: <span class="bold">132/70</span> mm Hg, HR: 76 /min, RR: 18 /min, Wt: 170 lbs, Ht: 72 in, BMI: <span class="bold">23.05</span> Index, Smoking: no, Pain scale: 0 1-10.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Physical Examination:</span> <br/>   General: Elderly male in NAD, ATNC<br/>Head/Neck: PERRLA, EOMI, no jvd, supple, neck with full rom, throat: no exudates, ears: no injection, eyes: no conjunctival injection; sinuses: no tenderness<br/>Cardiac: S1, s2, rrr, no murmurs noted<br/>Pul: decreased breath sound bilateral, no wheezing, no rhonchi noted<br/>GI: soft, nt, nd, bs, no peritoneal signs<br/>Ex: no edema<br/>CN II-XII: intact<br/>Skin: no rash, no moles, no skin openings<br/>Neuro: AAO * 3.</td></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease - I12.0   2. Dependence on renal dialysis - Z99.2   3. End stage renal disease - N18.6   4. Chronic kidney disease due to diabetes mellitus - E11.22   5. Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin - E11.42   6. Type 2 diabetes mellitus with other specified complication - E11.69   7. Hyperlipidemia, unspecified - E78.5   8. Ischemic cardiomyopathy - I25.5   9. Chronic obstructive pulmonary disease, unspecified - J44.9   10. Pleural effusion, not elsewhere classified - J90   11. Primary insomnia - F51.01   12. Other chronic pain - G89.29   13. BMI 23.0-23.9, adult - Z68.23   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease</span> <br/>Notes: Blood pressure management with medications.<br/>- Continue current medications for blood pressure management. Medication as directed, take your blood pressure daily. Monitor renal indices, following a kidney-friendly diet, limiting sodium intake, avoid nephrotoxins  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Dependence on renal dialysis</span> <br/>Notes: Patient is on hemodialysis. Monitoring for worsening symptoms.<br/>- Continue hemodialysis.<br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">3. End stage renal disease</span> <br/>Notes: Patient is on hemodialysis. Monitoring for worsening symptoms.<br/>- Continue hemodialysis.<br/><br/><br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Chronic kidney disease due to diabetes mellitus</span> <br/>Notes: Management with Insulin and [REDACTED].<br/>- Continue Insulin and Losartan 100 milligram tab. <br/>monitor renal indices, avoid nephrotoxins, renal to follow PRN  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin</span> <br/>Notes: Advised healthy diet, control blood glucose, engage in regular physical activity/exercise, get adequate sleep, manage other risk factors, weight loss  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Type 2 diabetes mellitus with other specified complication</span> <br/>Notes: Advised strict adherence to diabetic diet, with focus on lowering cholesterol and triglycerides by dietary choices, take medications as prescribed  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Hyperlipidemia, unspecified</span> <br/>Notes: Management with Atorvastatin.<br/>- Continue Atorvastatin 40MG tab once daily.  <br/>Clinical Notes: -  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Ischemic cardiomyopathy</span> <br/>Notes: Continue current medication regimine <br/>Monitor for symptoms  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Chronic obstructive pulmonary disease, unspecified</span> <br/>Notes: Well controlled on Trilogy inhaler. Utilize Albuterol as needed.<br/>- Continue Trilogy inhaler.<br/>- Utilize Albuterol as needed.  </td></tr><tr><td/></tr><tr><td><span class="bold">10. Pleural effusion, not elsewhere classified</span> <br/>Notes: Recent hospitalization for acute on chronic shortness of breath. Secondary to bibasilar effusion.<br/>- Monitor for dyspnea and increased cough.  </td></tr><tr><td/></tr><tr><td><span class="bold">11. Primary insomnia</span> <br/>Notes: - Continue Trazodone 150 milligrams.<br/>- Encourage sleep hygiene.  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Other chronic pain</span> <br/>Notes: Pain currently controlled on current regimen. Deferred to pain management.<br/>- Continue current pain management regimen.<br/>- Deferred to pain management.  </td></tr><tr><td/></tr><tr><td><span class="bold">13. BMI 23.0-23.9, adult</span> <br/>Notes: Counseled the patient regarding maintaining a healthy body mass index and explained to them the importance of diet restrictions and exercising.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 1036F TOBACCO NON USER, 1126F AMNT PAIN NOTED NONE PRSNT, 1159F MED LIST DOCD IN RCRD, 1160F RVW MEDS BY RX/DR IN RCRD, 3075F SYST BP GE 130 - 139MM HG, 3078F DIAST BP &lt; 80 MM HG</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 Weeks,prn (Reason: f/u)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99350 ALF/IL EST. LEVEL 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>1036F TOBACCO NON USER. <br/>1126F AMNT PAIN NOTED NONE PRSNT. <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. <br/>3075F SYST BP GE 130 - 139MM HG. <br/>3078F DIAST BP &lt; 80 MM HG. </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronic signature of [REDACTED] , APRN  on [REDACTED] 04:24 PM EDT</td></tr><tr><td valign="top">Sign off status: Pending</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span"/></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], APRN</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 04:24 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td>HPI</td><td/><td colspan="2"/><td>[REDACTED] M being seen for management of his chronic conditions at SNF. PMH stated below. Pt is in NAD at bedside. Per nursing no new issues verbalized.</td></tr></tbody></table><br/><p>Physical Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td/><td/><td colspan="2"/><td><p>General: Elderly male in NAD, ATNC</p><p>Head/Neck: PERRLA, EOMI, no jvd, supple, neck with full rom, throat: no exudates, ears: no injection, eyes: no conjunctival injection; sinuses: no tenderness</p><p>Cardiac: S1, s2, rrr, no murmurs noted</p><p>Pul: decreased breath sound bilateral, no wheezing, no rhonchi noted</p><p>GI: soft, nt, nd, bs, no peritoneal signs</p><p>Ex: no edema</p><p>CN II-XII: intact</p><p>Skin: no rash, no moles, no skin openings</p><p>Neuro: AAO * 3</p></td></tr></tbody></table><br/></li></ul></div><br/><br/>
</body></html>